Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study.

MLA

Moraly, Josquin, et al. “Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Systemic Mastocytosis: A Nationwide French Pilot Study.” American Journal of Hematology, vol. 99, no. 6, June 2024, pp. 1095–102. EBSCOhost, https://doi.org/10.1002/ajh.27323.

APA

Moraly, J., Rossignol, J., Rouzaud, C., Gabas, T., Bouktit, H., Lhermitte, L., Canioni, D., Fraitag, S., Bruneau, J., Barete, S., Suarez, F., Ballul, T., Meni, C., Polivka, L., Terriou, L., Launay, D., Bouillet, L., Gaudy-Marqueste, C., Gousseff, M., … Hermine, O. (2024). Efficacy and safety of mammalian target of rapamycin inhibitors in systemic mastocytosis: A nationwide French pilot study. American Journal of Hematology, 99(6), 1095–1102. https://doi.org/10.1002/ajh.27323

Chicago

Moraly, Josquin, Julien Rossignol, Claire Rouzaud, Thomas Gabas, Hassiba Bouktit, Ludovic Lhermitte, Danielle Canioni, et al. 2024. “Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Systemic Mastocytosis: A Nationwide French Pilot Study.” American Journal of Hematology 99 (6): 1095–1102. doi:10.1002/ajh.27323.